| NCT Number | NCT07243366 |
| Lead Sponsor | Guangdong ProCapZoom Biosciences Co., Ltd. |
| Conditions | Refractory Myasthenia Gravis |
| Enrollment | 15 participants |
| Start Date | 2025-11-25 |
| Primary Completion | 2027-06-30 (estimated) |
| Study Completion | 2027-11-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-11-21 |